journal article·2025-07Open access

Development and Stability of a New Brain Phantom for Leachables Screening from Deep Brain Stimulations Probes

Yassine Bouattour, Rodayna Hmede, Carine Chassain, Frédéric Chapelle, Guilhem Pagès, Céline Lambert, Philip Chennell, Rémi Chaix, Valérie Sautou, Jean‐Jacques Lemaire

Advanced Materials Technologies· Volume 10· Issue 13

Abstract

Abstract Implantable medical devices must meet biocompatibility requirements before clinical use, making the profiling of extractables and leachables crucial for assessing risks. Although guidelines outline methods for identifying extractables, they lack guidance on the monitoring of leachables. This study evaluates the stability of a brain phantom stored at 37 °C for 180 days for leachables monitoring. White matter (WM) and gray matter (GM) components, creating an emulsion‐gel with cholesterol, agar, and carboxymethylcellulose, are separated. Homogeneity is assessed using polydispersity index (PDI), and stability is investigated using Young's modulus (YM), rheological behavior, and apparent diffusion coefficient of water (ADCs) immediately after preparation and after 180 days of storage. PDI values are 0.258 ± 0.009 for WM and 0.362 ± 0.008 for GM. YM values are 2.32 ± 0.14 kPa for WM and 1.11 ± 0.11 kPa for GM. Dynamic viscosities are 16.62 ± 6.36 kPa s for WM and 5.99 ± 2.79 kPa s for GM at 0.1 rad s−1. ADCs are 1130 ± 64 µm2 s−1 for WM and 1449 ± 34 µm2 s−1 for GM. All parameters remain within physiological range during 180 days at 37 °C. Comparison with clinical data is necessary to validate this medium for leachable studies.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Neurological disorders and treatments · Neuroscience and Neural Engineering · Advanced MRI Techniques and Applications

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Université Clermont Auvergne CHU Clermont Ferrand Clermont Auvergne INP CNRS ICCF Clermont‐Ferrand F‐63000 France

Université Clermont Auvergne CNRS Clermont Auvergne INP Institut Pascal Clermont‐Ferrand F‐63000 France

INRAE ISC AgroResonance Saint‐Genès‐Champanelle F‐63122 France

Unité de Biostatistiques DRCI CHU Clermont‐Ferrand Clermont‐Ferrand F‐63000 France

Service de Neurochirurgie CHU Clermont‐Ferrand Clermont‐Ferrand F‐63000 France

References (85)

Show source-provided references
1. 10.1016/j.tins.2023.03.00910.1016/j.tins.2023.03.009 ↗
2. Amon A. · Neuromodulation: Technol. Neural Interface · 2023
3. 10.3389/fbioe.2022.81820110.3389/fbioe.2022.818201 ↗
4. 10.4103/2152-7806.8547310.4103/2152-7806.85473 ↗
5. 10.3389/fbioe.2021.65787510.3389/fbioe.2021.657875 ↗
6. 10.1002/jbm.82025100810.1002/jbm.820251008 ↗
7. 10.1191/0960327105ht587oa10.1191/0960327105ht587oa ↗
8. Sd B. · Med. Progress Technol. · 1990
9. 10.1007/978-3-030-35241-7_410.1007/978-3-030-35241-7_4 ↗
10. 10.1021/acs.est.1c0110310.1021/acs.est.1c01103 ↗
11. 10.1016/j.chemosphere.2022.13522710.1016/j.chemosphere.2022.135227 ↗
12. 10.1007/978-3-030-35241-7_1210.1007/978-3-030-35241-7_12 ↗
13. 10.5731/pdajpst.2020.01262410.5731/pdajpst.2020.012624 ↗
14. C. for D. R. Health FDA2022.
15. C. for D. R. Health “Use of International Standard ISO 10993‐1 ‘Biological evaluation of medical devices – Part 1: Evaluation and testing within a risk management process ’” can be found underhttps://www.fda.gov/regulatory‐information/search‐fda‐guidance‐documents/use‐international‐standard‐iso‐10993‐1‐biological‐evaluation‐medical‐devices‐part‐1‐evaluation‐and 2023.
16. Gately M. E. · Regulatory Focus · 2021
17. Regulation April 2017 (EU) 2017/745 of the European Parliament and of the Council of 5on Medical Devices Amending Directive 2001/83/EC Regulation (EC) No 178/2002 and Regulation (EC) No 1223/2009 and Repealing Council Directives 90/385/EEC and 93/42/EEC (Text with EEA Relevance.) 2017.
18. International Organization for Standardization “ISO 10993‐18:2020 ” can be found underhttps://www.iso.org/fr/standard/64750.html 2020.
19. 10.1177/193229682090865610.1177/1932296820908656 ↗
20. 14:00‐17:00 “ISO 10993‐18:2020 ” can be found underhttps://www.iso.org/fr/standard/64750.html 2023.
21. 10.1021/acsomega.2c0647310.1021/acsomega.2c06473 ↗
22. 10.22203/eCM.v033a0710.22203/eCM.v033a07 ↗
23. 10.1038/s41578-019-0150-z10.1038/s41578-019-0150-z ↗
24. 10.1016/j.ultrasmedbio.2013.08.02010.1016/j.ultrasmedbio.2013.08.020 ↗
25. 10.1016/S0022-2275(20)39619-X10.1016/S0022-2275(20)39619-X ↗
26. 10.1016/j.bbalip.2015.02.00710.1016/j.bbalip.2015.02.007 ↗
27. 10.1016/j.cell.2004.08.02610.1016/j.cell.2004.08.026 ↗
28. 10.1038/nm166810.1038/nm1668 ↗
29. 10.1038/sj.mp.400213710.1038/sj.mp.4002137 ↗
30. 10.1098/rsfs.2010.002510.1098/rsfs.2010.0025 ↗
31. 10.1073/pnas.120590210910.1073/pnas.1205902109 ↗
32. 10.3171/jns.2004.101.2.031410.3171/jns.2004.101.2.0314 ↗
33. M.Saliège A.Boyer‐Grand J.‐J.Lemaire J.Chopineau V.Sautou J.Gabrillargues A.Coste L.Sakka J.Coste F.Tixier et al. 2010.
34. 10.1371/journal.pone.007034310.1371/journal.pone.0070343 ↗
35. 10.1002/mrm.2746410.1002/mrm.27464 ↗
36. 10.1002/jmri.2058310.1002/jmri.20583 ↗
37. 10.1002/acm2.1353310.1002/acm2.13533 ↗
38. 10.3390/fluids609031210.3390/fluids6090312 ↗
39. 10.1080/03639045.2017.129167210.1080/03639045.2017.1291672 ↗
40. 10.1016/S0895-6111(00)00083-510.1016/S0895-6111(00)00083-5 ↗
41. 10.1038/s41597-024-04053-x10.1038/s41597-024-04053-x ↗
42. 10.3390/inorganics604011210.3390/inorganics6040112 ↗
43. Yu X. · BioPharm Int. · 2010 · 23 · 26
44. 10.5731/pdajpst.2018.00975310.5731/pdajpst.2018.009753 ↗
45. Chaturvedi P. R. · Acta Pharm. Nord. · 1992 · 4 · 51
46. 10.1088/0031-9155/45/4/30410.1088/0031-9155/45/4/304 ↗
47. 10.1088/0031-9155/50/23/01310.1088/0031-9155/50/23/013 ↗
48. 10.1002/jmri.2395010.1002/jmri.23950 ↗
49. 10.1023/A:101583651289010.1023/A:1015836512890 ↗
50. 10.1016/j.talanta.2012.03.02810.1016/j.talanta.2012.03.028 ↗
51. 10.1001/archpsyc.55.3.21510.1001/archpsyc.55.3.215 ↗
52. Nemich S. · Syst. Rev. Pharm. · 2017 · 8 · 39
53. 10.3746/pnf.2019.24.3.22510.3746/pnf.2019.24.3.225 ↗
54. 10.1016/j.jconrel.2016.06.01710.1016/j.jconrel.2016.06.017 ↗
55. 10.1016/B978-0-323-91077-4.00006-510.1016/B978-0-323-91077-4.00006-5 ↗
56. 10.1016/j.polymer.2023.12567210.1016/j.polymer.2023.125672 ↗
57. 10.13182/FST11‐A1270910.13182/FST11‐A12709 ↗
58. 10.1016/j.foodhyd.2015.12.01110.1016/j.foodhyd.2015.12.011 ↗
59. 10.1016/j.jmbbm.2015.02.02410.1016/j.jmbbm.2015.02.024 ↗
60. 10.1016/j.jbiomech.2011.01.01910.1016/j.jbiomech.2011.01.019 ↗
61. Garo A. · Biorheology · 2007 · 44 · 51
62. 10.1007/s10237-016-0860-810.1007/s10237-016-0860-8 ↗
63. 10.3233/BIR-2010-057610.3233/BIR-2010-0576 ↗
64. 10.1016/0021-9290(70)90007-210.1016/0021-9290(70)90007-2 ↗
65. Prange M. T. · Stapp Car Crash J. · 2000 · 44 · 205
66. Nicolle S. · Stapp Car Crash J. · 2004 · 48 · 239
67. 10.1016/j.mri.2008.01.04210.1016/j.mri.2008.01.042 ↗
68. Helenius J. · Am. J. Neuroradiol. · 2002 · 23 · 194
69. 10.1002/mrm.2205510.1002/mrm.22055 ↗
70. 10.1158/0008-5472.CAN-13-353410.1158/0008-5472.CAN-13-3534 ↗
71. 10.1016/j.ces.2021.11725710.1016/j.ces.2021.117257 ↗
72. 10.1371/journal.pone.028625110.1371/journal.pone.0286251 ↗
73. “Technical guideline on the evaluation of extraction efficiency of residue analytical methods ” can be found underhttps://www.hse.gov.uk/pesticides/pesticides‐registration/data‐requirements‐handbook/technical‐guideline.htm 2023.
74. 10.3390/polym1201013810.3390/polym12010138 ↗
75. 10.1002/adma.20240779410.1002/adma.202407794 ↗
76. 10.1039/C7CS00638A10.1039/C7CS00638A ↗
77. 10.1016/j.actbio.2019.11.01010.1016/j.actbio.2019.11.010 ↗
78. 10.1016/j.crfs.2021.06.00310.1016/j.crfs.2021.06.003 ↗
79. 10.1016/j.ejrad.2021.10969610.1016/j.ejrad.2021.109696 ↗
80. “.I. C. Harmonization (ICH) Quality Guidelines. Guidelines for Stability Q1A to Q1f. ” can be found underhttps://www.ich.org/page/quality‐guidelines 2021.
81. E.Pharmacopoeia “Monograph 2.9.20. testing for particulate contamination in pharmaceutical preparations ” can be found underhttps://www.edqm.eu/en/w/european‐pharmacopoeia‐updates‐testing‐for‐particulate‐contamination‐in‐pharmaceutical‐preparations 2021.
82. 10.1002/andp.1908330030210.1002/andp.19083300302 ↗
83. 10.1021/acsomega.1c0041110.1021/acsomega.1c00411 ↗
84. 10.1089/ten.teb.2010.052010.1089/ten.teb.2010.0520 ↗
85. 10.1016/j.matlet.2006.04.07810.1016/j.matlet.2006.04.078 ↗